![Cattura](https://archive.cancerworld.net/wp-content/uploads/2017/07/Cattura-89-619x381.png)
Bringing the new wave of targeted cancer drugs to the market poses new challenges for researchers and clinicians. It is not enough to design a smart drug to hit a molecular target. Researchers need to know how to test and develop the drug. The potential prizes are enormous so is the price of failure.
Leave a Reply